Moorfields Eye Hospital Dubai first colour vision study of the UAE’s diabetic population shows that ‘colour blindness’ is not a black and white issue

[:en]
10 June 2013 (Dubai, United Arab Emirates):  Moorfields Eye Hospital Dubai has revealed some of the findings of its first UAE colour vison study, undertaken by specialists from the hospital amongst people with diabetes in the UAE population. One of the unexpected findings was that significant colour vision defects were revealed in the vast majority of the tested Emirati population, which includes local people with and without diabetes. The general causes of ‘colour blindness’ (colour vision defects) are well known but the Moorfields study findings need more research to asses whether this UAE revelation is due to genetic or acquired factors (such as excessive exposure to sunlight or Vitamin D deficiency), according to the team at Moorfields.
What is commonly referred to as ‘colour blindness’ is not blindness at all but rather a colour vision deficiency – an inability or decreased ability to see colour or perceive colour differences under normal lighting conditions.
The first scientific paper on colour ‘blindness’ was published by an English chemist – John Dalton – in 1798, when he realised that he was colour blind. The paper was titled ‘Extraordinary facts relating to the vision of colours’.
Color blindness affects a significant number of people and especially isolated communities with a restricted gene pool. More than 95 percent of all variations in human colour vision involve the red and green receptors in male eyes and it is very rare for males or females to be ‘blind’ to the blue end of the spectrum.
An Ishihara colour test consisting of a series of pictures of coloured spots, is the test most often used to diagnose red–green colour deficiencies, with a shape or number embedded in the picture and which can be seen with normal colour vision but not with a colour defect.
The cause of colour blindness is now well known and understood and is related to a fault in the development of one or more sets of retinal ‘cones’ that perceive colour in light and transmit that information to the optic nerve. It is more common amongst men than women because it is linked to the genes, although eye or brain damage can also produce similar symptoms.
‘Colour blindness’ can be stationary or progressive in nature and can be linked to other eye conditions such as age related macular degeneration. It can be total (much less common) or partial and there are two major types of colour blindness: difficulty distinguishing between red and green, difficulty distinguishing between blue and yellow. Around 8 percent of males but only 0.5 percent of females are colour blind in some way or another.
One of the Moorfields researchers, Dr Imran Ansari – an Ophthalmologist at Moorfields Eye Hospital Dubai – comments: “There are different forms of ‘colour blindness’ which may have a variety of long term lifestyle implications as there is no cure. The condition may be acquired or inherited (congenital). It is usually classed as a mild disability and whilst it can be debilitating to some degree, there are also some situations where it can actually be an advantage, such as penetrating certain colour camouflages. Of course, there are some occupations in which ‘colour blindness’ is a distinct disadvantage, where recognising colour codes could be an important safety factor, such as when driving cars or flying aircraft, for example.”

Moorfields Eye Hospital Dubai supports 15th Emirates Ophthalmology Congress in Dubai (12-14 December 2013) with the participation of leading consultants

[:en]10 December 2013 (Dubai, United Arab Emirates): Moorfields Eye Hospital Dubai (Moorfields) will support the 15th Emirates Ophthalmology Congress in Dubai, with the active participation of some of its leading consultants who will moderate and present at the event. The annual congress will focus on updates and innovations in ophthalmology and will attract the leading practitioners in the field from the UAE, Middle East and other countries, including the full 10-strong team of ophthalmology consultants and other members of the clinical team at Moorfields Eye Hospital Dubai.
The 2013 Emirates Ophthalmology Congress meeting will be a forum for the latest advances, reviews of current theory and practice, and hands-on problem-based learning. Participants will gain insights into the most effective advances in the diagnosis and management of eye disease and prevention of blindness. Subspecialty sessions will cover the topics of Retina, Glaucoma, Cataract and Refractive surgery. A comprehensive poster program will be featured and will be digitally available at all times.
Dr Avinash Gurbaxani, Consultant Ophthalmic Surgeon in Uveitis and Medical Retinal Diseases at Moorfields, will speak at the symposium on ‘the micro biome and auto immune disease’ – a relatively new concept which explores the complex relationship between the vast amount of bacteria that inhabit the human body and their interaction with our genes and immune system.
Dr Edoardo Zinicola, Consultant Ophthalmologist at Moorfields, will moderate the Retina session and also present on Central Retinal Vein Occlusion.
Dr Qasiem Nasser, Consultant Ophthalmic Surgeon and Oculoplastics Specialist at Moorfields, will speak about the oculoplastic surgical evaluation of the upper eyelid.
According to Dr Nasser, the most common procedure in facial cosmetic surgery is performed on the upper and lower eyelids – ‘blepharoplasty’. Around 250,000 procedures are performed every year around the world. However, whilst it is a common procedure, the results can vary significantly from patient expectations. “Traditional Blepharoplasty has an enormous potential for disaster. There is no perfect aesthetic procedure and it is very much a case of understanding each patient’s exact problem and addressing it accordingly.”

Moorfields Eye Hospital Dubai and THE VISION CARE INSTITUTE® of Johnson & Johnson collaborate on a professional seminar for the region’s opticians

[:en]9 February 2014 (Dubai, United Arab Emirates): Leadingeye experts from Moorfields Eye Hospital Dubai (Moorfields) presented a professional seminar recently for 26 eye care professionals from across the GCC, organised and hosted by THE VISION CARE INSTITUTE® (The Institute) at Dubai Health Care City. The seminar focused on common conditions and patient questions and concerns around glaucoma – the second leading cause of blindness in the world – and oculoplastics (cosmetic surgery around the eyes).
During the seminar, Consultant Ophthalmic Surgeon and Oculoplastics Specialist at Moorfields Dubai, Dr Qasiem Nasser, discussed the evaluation of the upper eyelid from an oculoplastic perspective in response to the common patient complaint of ‘droopy eyelids’. Eye specialists especially are well equipped to undertake cosmetic procedures around the eyes because of their background knowledge in the specific area of the eye solely and exclusively.
Dr Sohaib Mustafa, Consultant Ophthalmic Surgeon and Glaucoma Specialist at Moorfields Dubai, then covered Glaucoma,discussing the detection, referral and management of the disease. Glaucoma is the second leading cause of blindness worldwide and the number one cause of irreversible blindness. However, the disease is treatable and blindness can be prevented through early diagnosis. Although children and young adults can be affected by Glaucoma, high risk groups include older` people (with an increasing risk over 40 years ofage), uncontrolled diabetics and those with a family history of glaucoma. The World Health Authority estimates that Glaucoma affects around 60 million people globally. Glaucoma is called “the sneak thief of sight” because there are no symptoms and once vision is lost, it is permanent. As much as 40 percent of vision can be lost without a person noticing.
Commenting on the seminar, Dr Clare Roberts, Medical Director at Moorfields Eye Hospital Dubai, said: “Training – alongside research and treatment – is an integral part of the Moorfields mission in the region and we are delighted to be working alongside THE VISION CARE INSTITUTE® which shares inour commitment to a patient-led approach to continual medical education. The Institute provides world class training facilities and resources, dedicated to improving the professional standards of eye care professionals in the region. By focusing on frontline eye care professionals, we can make a real difference to theirpatients by helping them identify potential problems even before there are any symptoms. Glaucoma is a great example – screening for the disease and then compliance with the treatment regime are two importantmessages for the professional community to share with their patients.”
THE VISION CARE INSTITUTE® in Dubai Health Care City, Dubai, offers continual education to eye care professionals all over the Middle East, with the aim of fostering a more confident and proactive approach to eye care. The Institute has state of the art facilities and technology to deliver innovative eye care education and has welcomed over 5,000 delegates since opening in the Middle East in 2008.Type your content here…

Dr. Muralidharan Upendran


MBBS, MS (Ophth), MRCOphth, FRCOphth
Consultant Ophthalmologist
Vitreo-Retinal Surgeon
GCAA Approved Specialist Medical Examiner]Dr. Muralidharan Upendran is a Consultant Ophthalmologist with sub-specialist training in Vitreo-Retinal surgery. He specialises in the surgical management of retinal disorders including retinal detachment, macular disease, diabetic retinopathy and ocular trauma. He also specializes in the medical management of retinal vascular disease and macular disorders. He is also an experienced cataract surgeon and can manage complex cataract surgery.
Dr. Upendran obtained his medical degree and a basic ophthalmology degree in India. He then moved to the UK where he received further higher specialty training in Ophthalmology in Belfast before becoming a Fellow of the Royal College of Ophthalmologists, London. He received his initial Vitreo-Retinal surgical training at the Royal Victoria Hospital in Belfast. He then received his fellowship training in Vitreo-Retinal surgery at the Birmingham & Midland Eye Centre, UK. He has recently worked as a Consultant Ophthalmologist with a special interest in retinal disease at the Royal Victoria Hospital and Macular Service in Belfast.
Dr. Upendran has an interest in research and teaching. He has a portfolio of published research and has delivered scientific presentations to his peers. He has been involved in teaching programs for medical students. He is a fellow of the Royal College of Ophthalmologists London and a Life member of the All India Ophthalmological Society.

Dr. Paola Salvetti

MD
Consultant Ophthalmologist
Specialist in Medical Retina
Clinical Lead Aviation Medicine
GCAA Approved Specialist Medical Examiner
CASA Designated Aviation Ophthalmologist Dr. Paola Salvetti is an experienced ophthalmologist and retina specialist with substantial clinical and research experience in the diagnosis and treatment of retina diseases, gained in the USA, France and Italy. In addition, Dr Salvetti has a special interest in aviation ophthalmology, neuroscience research and assessing and treating children with varying degrees of eyesight disability.
Dr. Salvetti studied medicine and ophthalmology in her native Italy prior to undertaking a fellowship at Harvard Medical School in Boston, USA. She was a Retina Fellow at the Schepens Eye Research Institute & Massachusetts Eye and Ear Infirmary, Harvard Medical School in Boston, before taking up a position as a General Ophthalmologist & Medical Retina Specialist and neurophthalmology physician in France; she was then appointed Medical Director of the Centro Oculistico Bergamasco in Italy.
Dr. Salvetti has undertaken a significant amount of published research work and presentations in her specialist areas and is a member of the Association of Research in Vision and Ophthalmology.
Click here to read more on Glaucoma.
Click here to read more on Common Eye Conditions.

Dr. Mohammed Sohaib Mustafa

MBBCh, PGDip, MRCOphth, FEBO, FRCS
Consultant Ophthalmic Surgeon, Specialist in Glaucoma and Cataract Surgery
GCAA Approved Specialist Ophthalmologist and Aeromedical Examiner
Associate Professor of Ophthalmology (Adjunct) Dr. Mustafa is a General Ophthalmic Surgeon and subspecialist in Glaucoma & Cataract, with experience in the latest surgical techniques in complex glaucoma management including microdrainage devices, laser treatment and less invasive techniques. Dr. Sohaib is also an experienced Cataract Surgeon. He performs complex Cataract with premium IOL options for both Glaucoma and non-Glaucoma patients. Dr Sohaib specialises in imaging of the eye and Glaucoma assessment and treatment, through Ocular Coherence Tomography, Ocular Ultrasound and Biomicroscopy.
He is also a GCAA certified specialist Ophthalmologist and Aeromedical Examiner. He has many years of experience in management of eye conditions and surgery in aviation medicine.
Dr. Mustafa graduated in Medicine with a Commendation from the UK and undertook his residency in General Ophthalmology in the UK, having worked at The Royal Victoria Eye and Ear Hospital in Dublin, Ireland, and Aberdeen University Hospital in Scotland.
He undertook his fellowship training in Adult and Paediatric Glaucoma at Manchester University Hospital and Moorfields Eye Hospital in London, UK, working under eminent clinicians within the Glaucoma fraternity. He is a certified specialist in the UK and Europe, having also undertaken a Consultant Ophthalmic Surgeon post at Manchester Royal Eye Hospital.
He has attained a Postgraduate Diploma in Cataract and Refractive Surgery from UK and has trained on femtolaser platforms.
He is a member of the Royal College of Ophthalmologists in London and has gained fellowships from the European and United Kingdom boards in Ophthalmology.
His main research interests include compliance and the safety of glaucoma medications, efficacy and safety outcomes of the latest surgical techniques in glaucoma and cataract, including microdrainage devices, and simulation teaching of ocular ultrasound. He has published extensively in peer reviewed journals and presented his work at international and national meetings.
Dr. Mustafa continues to collaborate with colleagues in London on his research interests and latest patient management principles.

Dr. Avinash Gurbaxani


MB BS, DOMS, FRCS (Ed) (Ophth)
Consultant Ophthalmic Surgeon in Uveitis and Medical Retinal Diseases and Cataract Surgery
Chief of Retina Service, Moorfields UAE
Associate Professor Of Ophthalmology (Adjunct) Dr. Gurbaxani specialises in the assessment and management of uveitis and inflammatory eye disease (uveitis, infectious diseases, autoimmune diseases of the eye) as well as medical retinal disease, such as diabetes, macular degeneration and retinal vascular disease. He has broad experience in the diagnosis and management of complex inflammatory eye diseases, including the use of immunosuppression, as well as in treating retinal disease. Dr Gurbaxani is also skilled in managing complex cataract surgery associated with these diseases.
Dr. Gurbaxani trained in ophthalmology in Oxford and London, working at The Oxford Eye Hospital in Oxford, Kings College Hospital, St. Thomas’ Hospital and Moorfields Eye Hospital in London. He has worked at the prestigious Medical Eye Unit in London as well as completing a Uveitis Fellowship and Medical Retina Fellowship at Moorfields London and the Sydney Eye Hospital in Australia, before returning to Moorfields London as a locum consultant.
Dr Gurbaxani is experienced in initiating research projects and running clinical trials, and has regularly published and presented papers at national and international conferences. He is a member of several professional bodies including the Royal College of Opthalmologists (RCOphth), Royal College of Surgeons of Edinburgh (RCS) (Ed), American Academy of Ophthalmology (AAO).

Cyclodiode Laser Treatment

The diode laser is a highly concentrated beam of light, which can be used to target and treat a selected area. Sometimes, laser treatment is recommended in order to avoid or delay the need for more invasive surgery. The diode laser is used to produce very small burns in the ciliary body, which produces the watery fluid called aqueous humour, and is situated behind the iris (coloured part of your eye). The reduced production of aqueous humour causes the eye pressure to fall.

Vitrectomy Surgery

A vitrectomy surgery is microsurgery performed to remove the jelly and replace it by a saline solution, gas or a special type of silicone oil. The most common reasons for operating on the retina are retinal detachment, diabetes and scarring on the retina.
For more information about vitrectomy surgery in Dubai, contact us today.

Trabeculectomy

The operation to control the pressure within your eye is called a Trabeculectomy (trab-ec-u-lec-tomy). A Trabeculectomy operationis recommended for patients whose glaucoma continues to progress despite using eye drops and/or having laser treatment.The goal of the Trabeculectomy surgery is to help lower and control the eye pressure. The eye pressure is known as intraocular pressure. If this remains high, then further irreversible loss of vision from glaucoma may occur. This operation will not improve your vision or cure glaucoma, but aims to prevent or slow down further visual loss from glaucoma damage.

Squint Surgery In Children

This information aims to answer some of the questions you may have about squint surgery. The information does not cover everything as every patient and squint is different. Your surgeon will discuss your particular case with you. Please ask the clinical staff about anything you want to be made clear.

What are the aims of surgery?

  • To improve the alignment of the eyes, to make the squint smaller in size.
  • In some patients, to reduce or try to eliminate double vision or to protect or restore binocular vision.
  • Occasionally to improve head posture.

What happens before the day of surgery?

A pre-assessment is performed in the weeks leading up to the operation date.

What happens on the day of surgery?

Squint surgery is nearly always a day case procedure. Squint surgery is a common eye operation. It involves weakening or strengthening or altering the action of one or more of the extraocular muscles which move the eye. The muscles may be recessed (to weaken), resected (to strengthen), their insertions moved (to alter their action) or less commonly altered in some other way (advanced, plicated, tucked, belly sutured permanently to the globe etc).
The muscles are sutured into their new positions. The operation is carried out under general anaesthetic. The operation usually takes up to 60 minutes depending on the number of muscles that need surgery. Parents can go down to the operating theatre with your child and stay until he/she is asleep but cannot come in to watch the surgery. Remember to discuss which eye(s) is/are being operated on and why.

What are the success rates?

Overall about 90% patients/parents perceive some improvement in the squint after surgery. However, there is some unpredictability in the procedure, so that the squint may not be completely corrected by the operation. Many patients require more than one operation in their lifetime. If the squint returns it may be in the same or in the opposite direction and may occur at any time. The operation does not change visual acuity or refractive error. More patching may be needed after the operation.

Does the surgery cure the need for glasses or a lazy eye?

No, the operation does not aim to change the vision or need for glasses.

What are the risks of the operation?

Parents can be informed that squint surgery is generally a safe procedure. However, as with any operation, complications can and do occur. Generally these are relatively minor but on rare occasions they may be serious.

  • Under and overcorrection

The original squint may still be present (undercorrection) or the squint direction may change over (overcorrection). Occasionally a different type of squint may occur. Some patients may require another operation.

  • Double vision

Double vision after surgery is normal and often settles in days or weeks. Some patients may continue to experience double vision on side gaze. Permanent primary position diplopia is very rare in children.

  • Allergy/stitches

Mild allergy to postop drops: itching/irritation/ redness/puffiness of the eyelids. It usually settles quickly when the drops are stopped. Infection or abscess around the stitches. Cyst or granuloma related to the wound or sutures: occasionally needs further surgery.

  • Redness

Can take up to 3 months to resolve, occasionally the eye remains discoloured (red, yellowish) permanently, particularly with repeated operations.

  • Scarring

Most of the scarring of the conjunctiva not noticeable by three months, but occasionally visible scars will remain, especially with repeat operations.

  • Lost or slipped muscle

Muscle may slip back from new position during the operation or shortly after, limiting eye movements. May require further surgery and not always possible to correct. The risk of slipped muscle requiring further surgery is about 1 in 1,000.

  • Scleral perforation

If suture passed too deep or thin sclera: may require antibiotic treatment and laser/cryo treatment. Can affect sight (via endophthalmitis, vitreous haemorrhage, retinal detachment). Risk is up to 2%.

  • Infection

Infection is a rare complication but the risk increases if drops are not instilled as directed and treatment not sought promptly. Significant infection is extremely rare but in the worst cases can cause loss of vision in the eye (endophthalmitis, orbital cellulitis).

  • Loss of Vision

Very rare, loss of vision in the eye being operated can occur. Risk of serious damage to the eye or vision is approximately 1 in 30,000.

  • Anterior segment ischaemia

The blood circulation to the front of the eye can rarely be reduced following surgery, producing a dilated pupil and blurred vision. This usually only occurs in patients who have had multiple surgeries. The risk is about 1 in 13,000 cases.

  • Anaesthetic risks

Unpredictable reactions occur in around 1 in 20,000 cases and death in around 1 in 100,000.

What will it be like after the operation?

Eye(s) will be swollen, red and sore and the vision may be blurry. Start the drops that evening, and painkillers suitable for age of the child, such as paracetamol and ibuprofen suspension, can be taken. The pain usually wears off within a few days. The redness and mild discomfort can last for up to 3 months particularly with repeat squint operations.

Care after the operation

  • Use the eye drops as directed
  • Attend your follow up appointment(s) to ensure the eye is healing well
  • Use cooled boiled water and a clean tissue or cotton wool to clean any stickiness from the eyes
  • Don’t rub the eye(s)
  • No swimming for 4 weeks
  • Continue using glasses if have them
  • Your child will need a few days to one week off nursery or school.

Squint Surgery in Adults

This information aims to answer some of the questions you may have about squint surgery. However, it does not cover everything as every patient and squint is different. Your surgeon will discuss your particular case with you. Please ask the clinical staff about anything you want to be made clear.

What is the aim of surgery?

  • To improve the alignment of the eyes, to make the squint smaller in size.
  • In some patients, to reduce or try to eliminate double vision.
  • Occasionally to improve an abnormal position of the head.

How is the surgery done?

Squint surgery is a very common eye operation. It usually involves tightening or moving one or more of the outside eye muscles which move the eye. These muscles are attached quite close to the front of the eye under the conjunctiva, the clear surface layer. The eye is never taken out of the socket during surgery. Stitches are used to attach the muscles in their new positions.
Squint surgery is nearly always a day case procedure so you should be in and out of hospital on the same day.
There are two kinds of squint operation – adjustable and non-adjustable:

Non adjustable surgery

The operation is usually carried out under general anaesthetic. The operation usually takes up to 60 minutes depending on the number of muscles that need surgery. When you have recovered from the anaesthetic and the nurses are happy for you to be discharged, you are free to go home – usually a few hours later.

Adjustable surgery

Squint surgery using an adjustable suture may give a better result in certain types of squint e.g. patients who have had a squint operation before, patients with a squint due to injury or patients with thyroid eye problems.

Part 1 – The main operation

The main part of the operation is carried out in the operating theatre usually under general anaesthetic (with you asleep).

Part 2 – Adjusting the stitch

Once you have woken up from the anesthetic the final position of the muscles is adjusted when you are awake and able to look at a target. This is particularly useful for treating double vision. If you wear glasses for distance or near, these will need to be brought in with you for this part of the operation. Adjustment is usually done on the ward, after drops of anaesthetic have been put into the eye to take away any pain. You may however feel a pressure sensation.

Before the day of surgery

A pre-assessment is performed in the weeks leading up to the operation date.

What happens on the day of surgery?

You will be asked to come early so that you can be prepared for surgery. You should not drink or eat before the operation: the exact timings of this will be given before the day of the operation. Before being discharged after the operation, you will receive eye drops with instructions and a follow up appointment.

Does the surgery cure the squint?

Overall about 90% patients feel some improvement in their squint after surgery. The amount of correction that is right for one patient may be too much or too little for another with exactly the same size squint, so that the squint may not be completely corrected by the operation. Although the eyes may be straight just after surgery, many patients require more than one operation in their lifetime. If the squint returns it may drift in either the same or opposite direction. We can’t predict when that drift may occur.

What are the risks of the operation?

Squint surgery is generally a safe procedure. However, as with any operation, complications can and do occur. Generally these are relatively minor but on rare occasions they may be serious.

  • Under and overcorrection

As the results of squint surgery are not completely predictable, the original squint may still be present (undercorrection) or the squint direction may change over (overcorrection). Occasionally a different type of squint may occur. These problems may require another operation.

  • Double vision

You may experience double vision after surgery, as your brain adjusts to the new position of the eyes. This is common and often settles in days or weeks but may take months to improve. Some patients may continue to experience double vision when they look to the side in order to achieve a good effect when the eyes look straight ahead. Rarely, double vision whilst looking straight ahead can be permanent in which case further treatment might be needed. If you already experience double vision, you might experience a different type of double vision after surgery. Botulinum toxin injections are sometimes performed before surgery to assess your risk of this.

  • Allergy/stitches

Some patients may have a mild allergic reaction to the medication they have been prescribed after surgery. This results in itching/irritation and some redness and puffiness of the eyelids. It usually settles very quickly when the drops are stopped. You may develop an infection or abscess around the stitches. This is more likely to occur if you go swimming within the first four weeks after surgery. A cyst can develop over the site of the stitches, which occasionally needs further surgery to remove it.

  • Redness

The redness in the eye can take as long as 3 months to go away. Occasionally the eye does not completely return to its normal colour, particularly with repeated operations.

  • Scarring

Most of the scarring of the conjunctiva (skin of the eye) is not noticeable by three months, but occasionally visible scars will remain, especially with repeat operations.

  • Lost or slipped muscle

Rarely one of the eye muscles may slip back from its new position during the operation or shortly afterwards. If this occurs, the eye is less able to move around and, if severe, further surgery can be required. Sometimes it is not possible to correct this. The risk of slipped muscle requiring further surgery is about 1 in 1,000.

  • Needle penetration

If the stitches are too deep or the white of the eye is thin, a small hole in the eye may occur, which may require antibiotic treatment and possibly some laser treatment to seal the puncture site. Depending on the location of the hole, the sight may be affected. The risk of the needle passing too deeply is about 2%.

  • Anterior segment ischaemia

The blood circulation to the front of the eye can very rarely be reduced following surgery, producing a dilated pupil and blurred vision. This usually only occurs in patients who have had multiple surgeries. The risk is about 1 in 13,000 cases.

  • Infection

Infection is a rare complication but the risk  increases if drops are not instilled as directed and treatment not sought promptly. Significant infection is extremely rare but in the worst cases can cause loss of vision or the eye (endophthalmitis, orbital cellulitis).

  • Loss of vision

Although very rare, loss of vision in the eye being operated can occur from this surgery. Risk of serious damage to the eye or vision is approximately 1 in 30,000.

  • Anaesthetic risks

Anaesthetics are usually safe but there are small and potentially serious risks. Unpredictable reactions occur in around 1 in 20,000 cases and unfortunately death in around 1 in 100,000.
Remember: these complications are detailed for your information and that the vast majority of people have no significant problems. After the operation the eye(s) will be swollen, red and sore and the vision may be blurry. The eye may be quite painful.
Start the drops you have been prescribed that evening, and painkillers such as paracetamol and ibuprofen can be taken. The pain usually wears off within a few days. The redness and discomfort can last for up to 3 months particularly with adjustable and repeat squint operations.
You should not sign any legal documents or drive for 48 hours after the general anaesthetic.
We would advise that you may need one or occasionally two weeks off work. Work and normal activities including sport can be resumed as soon as you feel comfortable to do so. It is quite safe to use the eyes for visual tasks, for example reading, watching television. You should return for follow up as advised.

Summary of care after the operation

  • Use the eye drops
  • Use painkillers such as paracetamol and ibuprofen if the eyes are painful
  • Use cooled boiled water and a clean tissue or cotton wool to clean any stickiness of the eyes and avoid water entering the eyes from the bath or shower for the first two weeks
  • Don’t rub the eye(s) as this may loosen the stitches
  • No swimming for 4 weeks
  • Attend the postop clinic appointment
  • Continue using glasses if you have them
  • Avoid contact lens wear in the operated eye(s) until advised it is safe by the doctor or orthoptist